Astra to challenge Roche in small cell lung cancer - Vantage

Astra to challenge Roche in small cell lung cancer  Vantage

An apparent success in the first-line SCLC Caspian trial could give Imfinzi a new use and allow it to challenge Roche in a setting where Tecentriq secured a US ...